| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute for Environmental Sciences [K. S.], and Department of Food and Nutritional Sciences, Graduate School of Nutritional and Environmental Sciences [N. Y., N. K.], University of Shizuoka, Shizuoka 422-8526; Department of Environmental Oncology, University of Occupational and Environmental Health, Kitakyushu 807-8555 [H. K.]; and Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Kyoto 606-8501 [S. T.], Japan
8-Hydroxy-2'-deoxyguanosine (8-OH-dG), which has been regarded as a potential marker of oxidative DNA damage induced by reactive oxygen species, was measured in human urine by a commercial ELISA using a monoclonal antibody N45.1 and by high-performance liquid chromatography (HPLC) coupled to an electrochemical detector (HPLC-ECD) to evaluate whether the ELISA system is applicable to human monitoring studies. The urine samples were collected from 120 healthy men ages 1858 in a steel-manufacturing company. A good correlation (r = 0.833; P < 0.0001) was observed between the two methods on HPLC-purified 8-OH-dG fractions from 23 urine samples. The mean value (±SD) of 8-OH-dG (µg/g creatinine) was 5.47 (±2.97) by HPLC-ECD assay and 5.50 (±2.36) by ELISA. However, the correlation (r) between the two methods on 120 original urine samples was 0.460 [P < 0.001; mean value (±SD) of 8-OH-dG (µg/g creatinine) was 4.46 (±2.03) by the HPLC assay and 9.33 (±3.23) by ELISA]. ELISA estimates were about 2-fold higher than the HPLC estimates on original urine. For an unknown reason, 10% of the urine samples showed more than a 4-fold increase in value by ELISA. It is suggested that the ELISA system is applicable for comparative human monitoring studies. Prepurification of samples is required to determine the absolute value of 8-OH-dG in individual urine samples by ELISA.
This article has been cited by other articles:
![]() |
M. S. Cooke, R. Olinski, S. Loft, and members of the European Standards Committee on Uri Measurement and Meaning of Oxidatively Modified DNA Lesions in Urine Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 3 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Peng, L.-Q. Li, M.-H. Peng, Z.-M. Liu, T.-W. Liu, Y. Guo, K.-Y. Xiao, Z. Qin, X.-P. Ye, X.-S. Mo, et al. Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1 a multi-center and multi-biomarker study Carcinogenesis, November 1, 2007; 28(11): 2347 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Komatsu, H. Kudoh, and Y. Kagawa Evaluation of Oxidative Stress and Effectiveness of Low-Dose Glucocorticoid Therapy on Exacerbation of Chronic Obstructive Pulmonary Disease J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Hu, C.-J. Wang, L. W. Chang, and M.-R. Chao Clinical-Scale High-Throughput Analysis of Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine by Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry with On-Line Solid-Phase Extraction Clin. Chem., July 1, 2006; 52(7): 1381 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizoue, H. Kasai, T. Kubo, and S. Tokunaga Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 582 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Siomek, A. Rytarowska, A. Szaflarska-Poplawska, D. Gackowski, R. Rozalski, T. Dziaman, M. Czerwionka-Szaflarska, and R. Olinski Helicobacter pylori infection is associated with oxidatively damaged DNA in human leukocytes and decreased level of urinary 8-oxo-7,8-dihydroguanine Carcinogenesis, March 1, 2006; 27(3): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamauchi, H. Nakano, J. Maekawa, Y. Okamoto, Y. Ohnishi, T. Suzuki, and H. Kimura Oxidative Stress in Obstructive Sleep Apnea Chest, May 1, 2005; 127(5): 1674 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, M. Lee, J.-U. Kim, K. I. Song, Y. S. Choi, and S.-S. Cheong Carvedilol Reduces Plasma 8-Hydroxy-2'-Deoxyguanosine in Mild to Moderate Hypertension: A Pilot Study Hypertension, May 1, 2005; 45(5): 986 - 990. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |